Biotest

Biotest Current Assets

Delisted

The Current Assets of Biotest (BIO.DE) as of Nov 11, 2026 is 808.80 M EUR. In the previous year, Current Assets was 754.50 M EUR — a change of 7.20% (higher).

Current Assets

808.80 MEUR

YoY

7.20%

Last updated:

Current Assets of Biotest is 2024 808.80 M EUR. Current Assets of Biotest was 2023 754.50 M EUR. It decreases by 7.20% higher compared to the previous year.

The Biotest Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2017
466.50 M EUR
Jan 1, 2018
491.80 M EUR
Jan 1, 2019
506.80 M EUR
Jan 1, 2020
549.70 M EUR
Jan 1, 2021
530.70 M EUR
Jan 1, 2022
610.70 M EUR
Jan 1, 2023
754.50 M EUR
Jan 1, 2024
808.80 M EUR
The Biotest Current Assets history
YEARCurrent AssetsYoY
808.80 MEUR+7.20%
754.50 MEUR+23.55%
610.70 MEUR+15.07%
530.70 MEUR-3.46%
549.70 MEUR+8.46%
506.80 MEUR+3.05%
491.80 MEUR+5.42%
466.50 MEUR-3.05%
481.20 MEUR-31.87%
706.30 MEUR+3.64%
681.50 MEUR+20.60%
565.10 MEUR+54.05%
366.82 MEUR-0.65%
369.23 MEUR+19.69%
308.49 MEUR-4.94%
324.51 MEUR-16.93%
390.64 MEUR+13.47%
344.26 MEUR+25.52%
274.27 MEUR+7.32%
255.57 MEUR+0.35%
254.69 MEUR-0.58%
256.18 MEUR-9.87%
284.24 MEUR+31.41%
216.31 MEUR+10.77%
195.28 MEUR+18.31%
165.07 MEUR+3.22%
159.91 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biotest Stock analysis

What does Biotest do? Biotest AG is an innovative and successful company that operates in the fields of medicine, pharmacy, and biotechnology. It was founded in 1946 by Dr. Carl Adolf Vorherr in Dreieich near Frankfurt am Main. The company's original focus was on the development, production, and distribution of blood plasma products. In the 1950s, Biotest expanded into the field of transfusion medicine and began to clinically examine and process blood from donors. It became a leading manufacturer of concentrate preparations for the treatment of immune deficiencies and blood coagulation disorders in the 1960s. In the 1970s, the company became a leading manufacturer of monoclonal and polyclonal antibodies and an important research and development facility for biotechnological applications. Biotest today is divided into five research and business areas: Hematology & Immunology, Clinical Immunology, Biotherapeutics, Dermatology, and Research and Development. The company is globally present with locations in Europe, North America, Asia, and South America. It employs over 2,500 people and its products are available in more than 90 countries. It invests in research and development to stay at the forefront of technology and improve global health. Biotest is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotest stock

Current Assets of Biotest is 808.80 M EUR in 2024.

Current Assets of Biotest changed from 754.50 M EUR to 808.80 M EUR, representing a 7.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Biotest since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Biotest historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Biotest

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Biotest